First Time Loading...

Merus NV
NASDAQ:MRUS

Watchlist Manager
Merus NV Logo
Merus NV
NASDAQ:MRUS
Watchlist
Price: 47.02 USD 4.7% Market Closed
Updated: May 2, 2024

Merus NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Merus NV
Revenue Peer Comparison

Comparables:
PHARM
PRQR
QURE
ARGX
N
NAMS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Merus NV
NASDAQ:MRUS
Revenue
$43.9m
CAGR 3-Years
14%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Revenue
$245.3m
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
43%
ProQR Therapeutics NV
NASDAQ:PRQR
Revenue
€9.5m
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Revenue
$15.8m
CAGR 3-Years
-25%
CAGR 5-Years
7%
CAGR 10-Years
14%
argenx SE
XBRU:ARGX
Revenue
$1.2B
CAGR 3-Years
210%
CAGR 5-Years
121%
CAGR 10-Years
N/A
N
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Revenue
€97.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Merus NV's Revenue?
Revenue
43.9m USD

Based on the financial report for Dec 31, 2023, Merus NV's Revenue amounts to 43.9m USD.

What is Merus NV's Revenue growth rate?
Revenue CAGR 5Y
3%

Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Merus NV have been 14% over the past three years , 3% over the past five years .